(CNN) — Certain blockbuster obesity drugs will be available for as little as $149 per month and more Medicare enrollees will have access to them under two deals announced Thursday by the Trump administration.

The arrangements with drugmakers Eli Lilly and Novo Nordisk, which President Donald Trump foreshadowed in remarks last month, are the latest in the administration’s efforts to lower drug prices. As part of the new deals, the drugmakers have also agreed to reduce prices for a wider array of drugs in Medicaid and the list prices when their medications first hit the market. In exchange, the drugmakers are getting breaks on tariffs on imported pharmaceutical products and a dramatically expedited regulatory review for certain medicines.

The prices consumers pay under the deals, howe

See Full Page